Integri AI
AI Agents Playground Voice AI PDF Chat Image Generation AI News Blog Pricing Help Contact Log In Sign Up Free

Mainstream UK Pharmacy Launches Medical Cannabis Service

Published 2026-11-17

Mainstream UK Pharmacy Launches Medical Cannabis Service | Integri News

A mainstream pharmacy in the United Kingdom has launched a new medical cannabis service, according to a report from the International Cannabis Business Conference. The move means that patients may be able to access medical cannabis products through a high street pharmacy rather than only through specialist clinics. The available information is limited, so details such as the pharmacy's name, the products offered and the launch date are not yet clear.

Medical cannabis has been legal in the UK since November 2018, when the government moved cannabis-based medicines into a more regulated group of drugs. These treatments can only be prescribed by doctors on the specialist register, and they cannot be sold over the counter. The NHS prescribes cannabis-based medicines only in limited situations, such as for some cases of severe epilepsy, multiple sclerosis and nausea caused by chemotherapy. Many patients who want medical cannabis for other conditions pay for private prescriptions.

For patients, a pharmacy service could make it easier to collect prescriptions and get advice from a trained professional. Supporters of medical cannabis say that it can help people with chronic pain and other long-term conditions. However, medical experts often point out that there is still limited large-scale research on how well these treatments work for many conditions, and that they can cause side effects, especially when mixed with other medicines.

The launch comes at a time when the debate about medical cannabis in the UK continues. Some politicians and health groups have called for clearer rules and more research, while others want wider access for patients. Any new service will need to follow the rules set by the Home Office, the Medicines and Healthcare products Regulatory Agency and the General Pharmaceutical Council. Readers who are interested in the service should speak to a doctor or pharmacist before making any decisions about their treatment.

Sources: International Cannabis Business Conference

More United Kingdom news

  • New US Restrictions on AI Chips Raise Concerns for Tech Stocks
  • US Tech Stocks Fall Sharply as Nasdaq 100 Drops 14% From Its October Peak
  • Markets Are Worried but Calm as US-China Tech Tensions Grow
  • Andy Burnham's Spending Priorities Face Criticism as UK Government Budgets Are Scrutinised
  • Andy Burnham Says Brexit Deal Is 'Not Good Enough for Britain'
  • New Australian Rules Require Most Backpackers to Work Longer in Regional Areas, But UK Citizens Are Exempt
  • Boots to Start Prescribing Medical Cannabis Online in the UK
  • Regulator Warns of Rising Overwork Among Trainee Obstetrics and Gynaecology Doctors

All United Kingdom news · News by country

Home Agents Pricing Blog News Help Privacy Policy Contact Login Sign Up